Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for MEN1-associated primary hyperparathyroidism
NL-OMON23587Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cinacalcet in primary hyperparathyroidism (PHPT) and Multiple endocrine neoplasia type 1 (MEN1), sponsored by Leiden University Medical Center. Primary endpoint: Effects of cinacalcet on clinical and biochemical parameters. Started Aug 2010; status: recruiting.
02
Drugs
cinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)Multiple endocrine neoplasia type 1 (MEN1)
Beyond the preview
Go deeper on NL-OMON23587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23587.